EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
Bao, Y; Oguz, G; Lee, WC; Lee, PL; Ghosh, K; Li, J; Wang, P; Lobie, PE; Ehmsen, S; Ditzel, HJ; Wong, A; Tan, EY; Lee, SC; Yu, Q
Lee, SC (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Yong Loo Lin Sch Med, Singapore 117597, Singapore.; Yu, Q (corresponding author), Agcy Sci Technol & Res, Canc Precis Med, Genome Inst Singapore, Biopolis, Singapore 138672, Singapore.; Lee, SC (corresponding author), Natl Univ Hlth Syst, Natl Univ Canc Inst, Dept Haematol Oncol, Singapore 119047, Singapore.; Yu, Q (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore.; Yu, Q (corresponding author), DUKE NUS Grad Med Sch Singapore, Canc & Stem Cell Biol, Singapore 169857, Singapore.
NATURE COMMUNICATIONS, 2020; 11 (1):
